Ledger.Open graph →
SEC Form D · filed April 11, 2019

Nimble Therapeutics, Inc

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Madison, WI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Rob C. Hart · San Francisco, CADirectorDeval Lashkari · San Francisco, CADirectorDapeng Xu · New York, NYDirectorAli Hamed · New York, NYDirectorJigar Patel · DULUTH, GAExec · DirectorGarth Ebanks · Grand Cayman, Cayman IslandsDirectorEthan Carlson · Providence, RIDirectorJigar Patel · DULUTH, GAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗